NO20060242L - Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin - Google Patents
Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatinInfo
- Publication number
- NO20060242L NO20060242L NO20060242A NO20060242A NO20060242L NO 20060242 L NO20060242 L NO 20060242L NO 20060242 A NO20060242 A NO 20060242A NO 20060242 A NO20060242 A NO 20060242A NO 20060242 L NO20060242 L NO 20060242L
- Authority
- NO
- Norway
- Prior art keywords
- agomelatine
- combination
- reuptake inhibitor
- serotonin reuptake
- serotonin
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002629 agomelatine Drugs 0.000 title abstract 2
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 title abstract 2
- 239000003772 serotonin uptake inhibitor Substances 0.000 title abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301031 | 2003-07-04 | ||
| US48547903P | 2003-07-07 | 2003-07-07 | |
| PCT/DK2004/000464 WO2005002562A1 (en) | 2003-07-04 | 2004-06-29 | The combination of a serotonin reuptake inhibitors and agomelatine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060242L true NO20060242L (no) | 2006-01-17 |
Family
ID=33566216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060242A NO20060242L (no) | 2003-07-04 | 2006-01-17 | Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20060205754A1 (enExample) |
| EP (1) | EP1643985B1 (enExample) |
| JP (1) | JP2007513052A (enExample) |
| KR (1) | KR20060032598A (enExample) |
| CN (1) | CN1852706A (enExample) |
| AR (1) | AR047553A1 (enExample) |
| AT (1) | ATE499096T1 (enExample) |
| AU (1) | AU2004253225A1 (enExample) |
| BR (1) | BRPI0411665A (enExample) |
| CA (1) | CA2530880A1 (enExample) |
| DE (1) | DE602004031527D1 (enExample) |
| DK (1) | DK1643985T3 (enExample) |
| IL (1) | IL172965A0 (enExample) |
| IS (1) | IS8154A (enExample) |
| MX (1) | MXPA06000018A (enExample) |
| NO (1) | NO20060242L (enExample) |
| WO (1) | WO2005002562A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2884714B1 (fr) * | 2005-04-20 | 2011-05-06 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires |
| FR2890564B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent |
| FR2890563B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
| FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
| WO2008035177A2 (en) * | 2006-09-18 | 2008-03-27 | Copharm | Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor |
| CA2685924A1 (en) * | 2007-05-01 | 2008-11-13 | Concert Pharmaceuticals Inc. | Naphthyl(ethyl)acetamides |
| US20080280991A1 (en) * | 2007-05-08 | 2008-11-13 | Auspex Pharmaceuticals, Inc. | Substituted naphthalenes |
| FR2956031B1 (fr) * | 2010-02-11 | 2012-03-02 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc) |
| WO2012054815A1 (en) | 2010-10-22 | 2012-04-26 | Duke University | Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
| PL2517700T3 (pl) * | 2011-04-28 | 2013-12-31 | Zentiva Ks | Farmaceutyczne dopuszczalne kokryształy n-[2-(7-metoksy-1-naftylo]acetamidu i sposoby ich wytwarzania |
| PH12012000132B1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
| WO2013013060A1 (en) * | 2011-07-19 | 2013-01-24 | Lycus, Llc | Agomelatine derivatives |
| EP2551257A1 (en) * | 2011-07-28 | 2013-01-30 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of agomelatine with co-crystal-formers |
| WO2014024896A1 (ja) * | 2012-08-08 | 2014-02-13 | 株式会社メドレックス | アゴメラチンを含有する貼付剤組成物 |
| WO2023154794A1 (en) * | 2022-02-09 | 2023-08-17 | University Of North Texas Health Science Center | Drug repurposing for delayed treatment of ischemic stroke |
| CN116570579A (zh) * | 2023-06-13 | 2023-08-11 | 深圳市泛谷药业股份有限公司 | 一种含有阿戈美拉汀和氟伏沙明的药物组合物及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5470846A (en) * | 1994-01-14 | 1995-11-28 | Sandyk; Reuven | Treatment of neurological and mental disorders |
| CA2134038C (en) | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| MX9700693A (es) | 1994-07-26 | 1997-04-30 | Pfizer | Derivados del 4-indol. |
| US5597826A (en) | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| EP0714663A3 (en) | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
| FR2744449B1 (fr) | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| SE9703375D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
| GB2336534A (en) * | 1998-04-24 | 1999-10-27 | Alec James Coppen | Anti-depressant - Folic Acid Combination |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| WO2002087566A1 (en) * | 2001-05-01 | 2002-11-07 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
| US6617891B2 (en) * | 2001-09-26 | 2003-09-09 | Intel Corporation | Slew rate at buffers by isolating predriver from driver |
| FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
-
2004
- 2004-06-28 AR ARP040102269A patent/AR047553A1/es unknown
- 2004-06-29 CA CA002530880A patent/CA2530880A1/en not_active Abandoned
- 2004-06-29 US US10/558,494 patent/US20060205754A1/en not_active Abandoned
- 2004-06-29 CN CNA2004800191380A patent/CN1852706A/zh active Pending
- 2004-06-29 BR BRPI0411665-8A patent/BRPI0411665A/pt not_active Application Discontinuation
- 2004-06-29 KR KR1020057024442A patent/KR20060032598A/ko not_active Withdrawn
- 2004-06-29 DE DE602004031527T patent/DE602004031527D1/de not_active Expired - Lifetime
- 2004-06-29 AT AT04738961T patent/ATE499096T1/de not_active IP Right Cessation
- 2004-06-29 JP JP2006517965A patent/JP2007513052A/ja active Pending
- 2004-06-29 EP EP04738961A patent/EP1643985B1/en not_active Expired - Lifetime
- 2004-06-29 WO PCT/DK2004/000464 patent/WO2005002562A1/en not_active Ceased
- 2004-06-29 MX MXPA06000018A patent/MXPA06000018A/es not_active Application Discontinuation
- 2004-06-29 AU AU2004253225A patent/AU2004253225A1/en not_active Abandoned
- 2004-06-29 DK DK04738961.4T patent/DK1643985T3/da active
-
2005
- 2005-11-28 IS IS8154A patent/IS8154A/is unknown
-
2006
- 2006-01-03 IL IL172965A patent/IL172965A0/en unknown
- 2006-01-17 NO NO20060242A patent/NO20060242L/no not_active Application Discontinuation
-
2010
- 2010-04-21 US US12/764,348 patent/US20100267772A1/en not_active Abandoned
-
2012
- 2012-07-19 US US13/552,699 patent/US20130217776A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004253225A1 (en) | 2005-01-13 |
| IL172965A0 (en) | 2006-06-11 |
| MXPA06000018A (es) | 2006-03-21 |
| EP1643985A1 (en) | 2006-04-12 |
| EP1643985B1 (en) | 2011-02-23 |
| BRPI0411665A (pt) | 2006-08-08 |
| WO2005002562A1 (en) | 2005-01-13 |
| ATE499096T1 (de) | 2011-03-15 |
| KR20060032598A (ko) | 2006-04-17 |
| US20130217776A1 (en) | 2013-08-22 |
| DK1643985T3 (da) | 2011-06-06 |
| CA2530880A1 (en) | 2005-01-13 |
| JP2007513052A (ja) | 2007-05-24 |
| DE602004031527D1 (de) | 2011-04-07 |
| US20100267772A1 (en) | 2010-10-21 |
| US20060205754A1 (en) | 2006-09-14 |
| AR047553A1 (es) | 2006-01-25 |
| IS8154A (is) | 2005-11-28 |
| CN1852706A (zh) | 2006-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060242L (no) | Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin | |
| EA200601760A1 (ru) | Тетрагидроиндазольные модуляторы каннабиноидов | |
| EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
| CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
| NO20074238L (no) | Fiksert dosering av HER-antistoffer | |
| PA8596901A1 (es) | Inhibidores de p38 y metodos de uso de ellos | |
| NO20053088L (no) | Farmasoytisk preparat inneholdende en beta-3-adrenoseptoragonist og en serotonin og/eller norepinefrin-gjenopptakelsesinhibitor og anvendelse av nevnte preparat for behandling av blaeredysfunksjon. | |
| ECSP11010975A (es) | Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales | |
| CY1109066T1 (el) | Παραγοντες δημιουργιας ελαιογελης που περιεχουν τριτερπενια, ελαιογελη που περιεχει τριτερπενια και μεθοδος για την παραγωγη ελαιογελης που περιεχει τριτερπενια | |
| EA200700035A1 (ru) | Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders | |
| DK1641456T3 (da) | Gaboxadol til behandling af depression og andre affektive lidelser | |
| EA200800889A1 (ru) | Гексагидроциклооктилпиразольные каннабиноидные модуляторы | |
| CY1110326T1 (el) | Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους | |
| WO2004052858A3 (en) | Inhibitors of monoamine uptake | |
| MY147518A (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
| BRPI0411175A (pt) | combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão | |
| BR0115301A (pt) | Uso de um inibidor seletivo da recaptação de norepinefrina | |
| NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
| EA200801399A1 (ru) | Замещённые 5-гетероарил-1-фенилпиразольные каннабиноидные модуляторы | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| NO20061427L (no) | Kombinasjonen av en serotonin-reoppttaksinhibitor og amoxapin | |
| NO20060229L (no) | Gaboxadol for behandling av depresjon og andre affektive lidelser | |
| EA200600531A1 (ru) | Сочетание ингибитора обратного захвата серотонина и локсапина | |
| EA200800890A1 (ru) | Модуляторы гексагидроциклогептапиразол каннабиноида | |
| HRP20050580A2 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |